Evaluating the acceptability and effectiveness of internet cognitive behaviour therapy

Not Applicable

Completed

• Conditions: Depression, Generalized Anxiety Disorder (GAD), Panic Disorder; Mental and Behavioural Disorders; Depressive episode, unspecified

• Registration Number: ISRCTN48160673
• Lead Sponsor: niversity of Regina (Canada)

Brief Summary

2012 Other publications in http://www.ncbi.nlm.nih.gov/pubmed/?term=22428582 Training provided to therapists 2014 Results article in https://pubmed.ncbi.nlm.nih.gov/25445078/ (added 10/11/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2013-04-01
• Study Start: 2014-02-04
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 221

Inclusion Criteria

1. Resident of Saskatchewan
2. Aged 18 years or older, either sex
3. Currently experiencing symptoms of depression, generalized anxiety, or panic
4. Has regular access to a computer, Internet, and printer
5. Comfortable using the internet and writing e-mails
6. For panic: PHQ-9 - score of 5 or above
7. Generalized Anxiety Disorder (GAD)-7 score of 5 or above
8. Panic Disorder Severity Scale (PDSS) score of 6 or above

Exclusion Criteria

1. Not a resident of Saskatchewan
2. Less than 18 years of age
3. Has no regular access to a computer, internet, and use of printer
4. Currently receiving psychotherapy elsewhere or in some other form
5. Started a new psychotropic medication within the past month or had a change in dosage
6. Meets criteria for current substance abuse or dependence (drugs or alcohol)
7. Meets current criteria for a psychotic disorder or bipolar disorder, or severe symptoms of depression, including frequent suicidal ideation

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Depression Anxiety Stress Scale-21 Item (DASS)<br> 2. Patient Health Questionnaire- 9 Item (PHQ-9)<br> 3. Generalized Anxiety Disorder ? 7 (GAD-7)<br> 4. Panic Disorder Severity Scale (PDSS)<br><br> Measured at baseline, during the study treatment (after the 6th module), at the end of treatment (after the final module) and at 3 months after completing the 12 modules.<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. World Health Organization Quality of Life Assessment BREF (WHOQOL-BREF)<br> 2. Work and Social Adjustment Scale (WSAS)<br> 3. Treatment Satisfaction questions<br> 4. Therapeutic Alliance Questionnaire (TAQ)<br><br> Measured at baseline, during the study treatment (after the 6th module), at the end of treatment (after the final module) and at 3 months after completing the 12 modules.<br>